Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.

@article{Kuhadiya2013LiraglutideAA,
  title={Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.},
  author={Nitesh D. Kuhadiya and Ritu Malik and Natalie J Bellini and Jane Lyons Patterson and Andrea N. Traina and Antoine Makdissi and Paresh Dandona},
  journal={Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists},
  year={2013},
  volume={19 6},
  pages={
          963-7
        }
}
OBJECTIVE Because approximately 40% of patients with type 1 diabetes have the metabolic syndrome, we tested the hypothesis that addition of liraglutide to insulin in obese patients with type 1 diabetes will result in an improvement in plasma glucose concentrations, a reduction in hemoglobin A1c (HbA1c), a fall in systolic blood pressure, and weight loss. METHODS This is a retrospective analysis of data obtained from 27 obese patients with type 1 diabetes treated with liraglutide in addition… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS

Similar Papers

Loading similar papers…